An update to "The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe"
Journal article published in 2010 by
Mark Jit 
,
Mjj Mangen,
Hugues Melliez,
Yazdan Yazdanpanah,
Joke Bilcke,
Heini Salo,
Wj John Edmunds,
Philippe Beutels
,
Mjj Mangen,
Hugues Melliez,
Yazdan Yazdanpanah,
Joke Bilcke,
Heini Salo,
Wj John Edmunds,
Philippe Beutels
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
A cost-effectiveness analysis of rotavirus vaccination in Belgium, England and Wales, Finland, France and the Netherlands published in 2009 was updated based on recent studies on rotavirus burden of disease and vaccine efficacy. All the qualitative conclusions in the previous study were found to remain valid. Vaccination remains cost-effective in Finland only when using plausible tender prices. (C) 2010 Elsevier Ltd. All rights reserved.